Stockscreener 앱 받기
1.205
1.26%
0.015
전일 마감가:
$1.19
열려 있는:
$1.22
하루 거래량:
29,768
Relative Volume:
0.39
시가총액:
$12.79M
수익:
$3,000
순이익/손실:
$-8.54M
주가수익비율:
-0.6985
EPS:
-1.7252
순현금흐름:
$-7.51M
1주 성능:
-2.82%
1개월 성능:
-2.82%
6개월 성능:
-41.50%
1년 성능:
-52.56%
1일 변동 폭
$1.18
$1.23
1주일 범위
$1.135
$1.3861
52주 변동 폭
$1.00
$3.20
Biocardia Inc Stock (BCDA) Company Profile
명칭
Biocardia Inc
전화
650-226-0123
주소
320 SOQUEL WAY, SUNNYVALE, CA
Compare BCDA vs PSNYW, SHMD, GOODO, DWLD, QQQE
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| 0.41 | 0 | 0 | 0 | 0 | 0.00 | |
PSNYW
Polestar Automotive Holding Uk
|
4.50 | 350.59M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
SHMD
Schmid Group N V
|
7.26 | 465.95M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.18 | 372.90M | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
45.25 | 0 | 0 | 0 | 0 | 0.00 |
|
QQQE
Direxion NASDAQ-100 Equal Weigh
|
103.33 | 0 | 0 | 0 | 0 | 0.00 |
Biocardia Inc Stock (BCDA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-04-16 | 다운그레이드 | Dawson James | Buy → Neutral |
Biocardia Inc 주식(BCDA)의 최신 뉴스
BioCardia Late Breaking Echocardiography Clinical Results from CardiAMP HF Trial Presented at Technology and Heart Failure Therapeutics (THT) - Bitget
BioCardia Highlights Positive CardiAMP Phase III Heart Failure Data - TipRanks
BioCardia reports positive echocardiography results from Phase III CardiAMP HF trial indicating reduced ventricular remodeling - TradingView
New CardiAMP HF echo data from BioCardia (NASDAQ: BCDA) highlight ventricular remodeling - Stock Titan
Heart failure cell therapy shows less adverse cardiac remodeling - Stock Titan
BCDA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BCDA Should I Buy - Intellectia AI
Loss Report: Can BioCardia Inc ride the EV wavePortfolio Profit Report & Daily Growth Stock Tips - baoquankhu1.vn
Chipmakers Recap: Does BioCardia Inc have pricing powerQuarterly Performance Summary & Fast Gaining Stock Reports - baoquankhu1.vn
S P Trends: Can BioCardia Inc. ride the EV waveMarket Trend Review & Verified Short-Term Plans - mfd.ru
BCDA PE Ratio & Valuation, Is BCDA Overvalued - Intellectia AI
How is BioCardia Inc. managing supply chain issuesMarket Volume Summary & Weekly Top Performers Watchlists - mfd.ru
Biocardia's Regulatory Milestone: FDA Submission Paves Way for Cardiac Delivery System () - aktiencheck.de
BioCardia submits FDA pre-submission for heart delivery catheter By Investing.com - Investing.com Nigeria
Biocardia files pre-submission for FDA approval of Helix(TM) - marketscreener.com
BioCardia (BCDA) Advances Helix Catheter Approval with FDA Pre-S - GuruFocus
BioCardia submits FDA pre-submission for heart delivery catheter - Investing.com
BioCardia Advances FDA Pathway for Helix Delivery Catheter - TipRanks
BioCardia Submits Pre-Submission to FDA for Helix Transendocardial Delivery Catheter Approval - Quiver Quantitative
BioCardia Files Pre-Submission for FDA Approval of Helix™ Transendocardial Delivery Catheter for Therapeutic and Diagnostic Agent Delivery to the Heart - marketscreener.com
BioCardia Files Pre-Submission for FDA Approval of Helix™ - GlobeNewswire
Catheter to deliver cell and gene therapies to the heart heads to FDA - Stock Titan
Insider Buying: Peter Altman Acquires Additional Shares of BioCa - GuruFocus
BioCardia’s CardiAMP Heart Failure Data Selected for LBCT - TipRanks
BioCardia Announces Late Breaking Echocardiography Results from the CardiAMP HF Trial to be Presented at Technology and Heart Failure Therapeutics (THT) - The Manila Times
BioCardia, Inc. Announces Presentation of CardiAMP HF Trial Data - TradingView
Heart failure cell therapy trial lands late-breaking THT slot for echo data - stocktitan.net
Insider Sell: Will Matador Resources Company benefit from geopolitical trendsDividend Hike & Weekly Momentum Stock Picks - baoquankhu1.vn
Activity Recap: Does BioCardia Inc have consistent dividend growthQuarterly Trade Review & Growth Oriented Trade Recommendations - baoquankhu1.vn
Aug Ideas: Whats Sono Tek Corporations historical returnPortfolio Value Report & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Chipmakers Recap: Should you avoid BioCardia Inc stock right now2025 Earnings Impact & Safe Swing Trade Setup Alerts - baoquankhu1.vn
IO Biotech (IOBT) Explores Strategic Alternatives, Stock Surges 19.36% - Intellectia AI
Altman Peter buys BioCardia (BCDA) shares worth $1,194 By Investing.com - Investing.com Nigeria
Altman Peter buys BioCardia (BCDA) shares worth $1,194 - Investing.com
Trend Review: Is BioCardia Inc. in a long term uptrendWeekly Investment Summary & Weekly Top Gainers Alerts - baoquankhu1.vn
US Stocks Recap: Can BioCardia Inc expand its profit marginsJuly 2025 Big Picture & Weekly Chart Analysis and Guides - baoquankhu1.vn
Swing Trade: Is BioCardia Inc stock forming a triangle patternGap Up & High Accuracy Trade Alerts - baoquankhu1.vn
Can BioCardia Inc. stock deliver surprise earnings beat2025 Buyback Activity & AI Enhanced Trade Execution Alerts - Bộ Nội Vụ
Published on: 2026-01-10 18:46:33 - Улправда
Will BioCardia Inc. (6JU0) stock keep high P E multiplesPortfolio Return Report & Reliable Entry Point Alerts - Улправда
Can BioCardia Inc. stock continue upward trendWeekly Stock Report & AI Optimized Trading Strategy Guides - Улправда
Forecast Cut: Will BioCardia Inc. stock rally after Fed decisionsJuly 2025 Weekly Recap & Daily Entry Point Alerts - ulpravda.ru
Will BioCardia Inc. stock rally after Fed decisionsMarket Activity Report & Community Trade Idea Sharing Platform - Улправда
How BioCardia Inc. stock reacts to bond yields2026 world cup usa national team qualification midfield engines set piece tactics expert forecast analysis - Улправда
Bull Run: Why analysts raise outlook for BioCardia Inc 6JU0 stock2025 Market Outlook & Daily Profit Focused Stock Screening - moha.gov.vn
Profit Review: Will BioCardia Inc 6JU0 stock sustain uptrend momentumJuly 2025 Volume & Safe Capital Growth Stock Tips - moha.gov.vn
Is BioCardia Inc 6JU0 a good long term investmentEconomic Indicators Overview & Free Stay Ahead With Picks - earlytimes.in
BioCardia (BCDA) Stock Analysis Report | Financials & Insights - Benzinga
BioCardia advances CardiAMP therapy in Japan - MSN
Will BioCardia Inc. stock deliver long term returns2025 Technical Patterns & Daily Growth Stock Tips - Улправда
Will BioCardia Inc. stock keep outperforming rivals2025 Winners & Losers & Weekly Top Performers Watchlists - Улправда
Biocardia Inc (BCDA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Biocardia Inc 주식 (BCDA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Altman Peter | President and CEO |
Jan 20 '26 |
Buy |
1.32 |
600 |
792 |
268,566 |
| Altman Peter | President and CEO |
Jan 21 '26 |
Buy |
1.34 |
300 |
402 |
268,866 |
| Altman Peter | President and CEO |
Dec 17 '25 |
Buy |
1.30 |
900 |
1,170 |
267,966 |
| Altman Peter | President and CEO |
Dec 16 '25 |
Buy |
1.37 |
200 |
274 |
267,066 |
| STERTZER SIMON H | Director |
Sep 19 '25 |
Buy |
1.25 |
398,400 |
498,000 |
591,054 |
| Blank Andrew Scott | Director |
Sep 19 '25 |
Buy |
1.25 |
288,000 |
360,000 |
634,023 |
| Altman Peter | President and CEO |
Sep 19 '25 |
Buy |
1.25 |
48,000 |
60,000 |
216,762 |
| Altman Peter | President and CEO |
Aug 22 '25 |
Buy |
1.83 |
700 |
1,281 |
168,762 |
| Altman Peter | President and CEO |
Aug 13 '25 |
Buy |
1.83 |
100 |
183 |
168,062 |
| Altman Peter | President and CEO |
Aug 12 '25 |
Buy |
1.75 |
400 |
700 |
167,962 |
3.69%
0.68%
자본화:
|
볼륨(24시간):